Detalhe da pesquisa
1.
Chromatin Remodeling Enzyme Cluster Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Breast Cancer.
Int J Mol Sci
; 24(6)2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982660
2.
Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.
Int J Med Sci
; 19(10): 1615-1627, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185333
3.
Silencing DNA Polymerase ß Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer.
Int J Mol Sci
; 22(5)2021 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33673690
4.
CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.
Exp Cell Res
; 363(1): 65-72, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305962
5.
Orchestration of H3K27 methylation: mechanisms and therapeutic implication.
Cell Mol Life Sci
; 75(2): 209-223, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717873
6.
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
Int J Mol Sci
; 20(17)2019 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31438571
7.
The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.
Exp Cell Res
; 359(2): 458-465, 2017 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28842166
8.
From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis.
Int J Mol Sci
; 19(11)2018 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30428588
9.
Connecting the Dots: From DNA Damage and Repair to Aging.
Int J Mol Sci
; 17(5)2016 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27164092
10.
ß1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.
Int J Mol Sci
; 17(9)2016 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27589736
11.
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.
J Pers Med
; 14(3)2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38540967
12.
Evaluating Recurrence Risk in Patients Undergoing Breast-conserving Surgery Using E-cadherin Staining as a Biomarker.
In Vivo
; 38(3): 1143-1151, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38688621
13.
Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment.
J Biol Chem
; 287(9): 6764-72, 2012 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22219182
14.
Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells.
J Cell Physiol
; 228(2): 341-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22718198
15.
SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer Patients.
Cancer Genomics Proteomics
; 20(6): 582-591, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889057
16.
Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer.
Biomed Pharmacother
; 163: 114732, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37254289
17.
The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy.
Exp Mol Med
; 55(5): 926-938, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37121970
18.
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer.
Biomedicines
; 11(3)2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36979671
19.
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort.
Biomedicines
; 11(12)2023 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137334
20.
Monoubiquitination of H2AX protein regulates DNA damage response signaling.
J Biol Chem
; 286(32): 28599-607, 2011 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21676867